332 related articles for article (PubMed ID: 36105483)
1. Quercetin Protects against MPP
Lin ZH; Liu Y; Xue NJ; Zheng R; Yan YQ; Wang ZX; Li YL; Ying CZ; Song Z; Tian J; Pu JL; Zhang BR
Oxid Med Cell Longev; 2022; 2022():7769355. PubMed ID: 36105483
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of Querectin against MPP
Jiang Y; Xie G; Alimujiang A; Xie H; Yang W; Yin F; Huang D
Front Biosci (Landmark Ed); 2023 Mar; 28(3):42. PubMed ID: 37005755
[TBL] [Abstract][Full Text] [Related]
3. Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson's disease.
Li QM; Xu T; Zha XQ; Feng XW; Zhang FY; Luo JP
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117196. PubMed ID: 37717841
[TBL] [Abstract][Full Text] [Related]
4. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson's disease via inhibiting oxidative stress and ferroptosis.
Li M; Zhang J; Jiang L; Wang W; Feng X; Liu M; Yang D
BMC Complement Med Ther; 2023 Jul; 23(1):218. PubMed ID: 37393274
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
Ren Y; Ye D; Ding Y; Wei N
Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596
[No Abstract] [Full Text] [Related]
9. Artemisinin protects dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in a mouse model of Parkinson's disease.
Lim HS; Park G
Biomed Pharmacother; 2024 Jan; 170():115972. PubMed ID: 38056239
[TBL] [Abstract][Full Text] [Related]
10. Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease.
Fu X; Qu L; Xu H; Xie J
Exp Neurol; 2024 May; 375():114724. PubMed ID: 38365133
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
12. Dl-3-n-butylphthalide activates Nrf2, inhibits ferritinophagy, and protects MES23.5 dopaminergic neurons from ferroptosis.
Ye Z; Li C; Liu S; Liang H; Feng J; Lin D; Chen Y; Peng S; Bu L; Tao E; Jing X; Liang Y
Chem Biol Interact; 2023 Sep; 382():110604. PubMed ID: 37315914
[TBL] [Abstract][Full Text] [Related]
13. Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson's Disease.
Shen J; Chen S; Li X; Wu L; Mao X; Jiang J; Zhu D
Neurochem Res; 2024 May; 49(5):1291-1305. PubMed ID: 38424396
[TBL] [Abstract][Full Text] [Related]
14. A Mechanism Study on the Antioxidant Pathway of Keap1-Nrf2-ARE Inhibiting Ferroptosis in Dopaminergic Neurons.
Yao Y; Li PS; Jiang S; Meng XL; Gao H; Yang XL
Curr Mol Med; 2024 Jan; ():. PubMed ID: 38178661
[TBL] [Abstract][Full Text] [Related]
15. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
16. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
[TBL] [Abstract][Full Text] [Related]
17. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
[TBL] [Abstract][Full Text] [Related]
18. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
19. In situ analysis of acupuncture protecting dopaminergic neurons from lipid peroxidative damage in mice of Parkinson's disease.
Zuo T; Xie M; Yan M; Zhang Z; Tian T; Zhu Y; Wang L; Sun Y
Cell Prolif; 2022 Apr; 55(4):e13213. PubMed ID: 35274781
[TBL] [Abstract][Full Text] [Related]
20. Pinostrobin Exerts Neuroprotective Actions in Neurotoxin-Induced Parkinson's Disease Models through Nrf2 Induction.
Li C; Tang B; Feng Y; Tang F; Pui-Man Hoi M; Su Z; Ming-Yuen Lee S
J Agric Food Chem; 2018 Aug; 66(31):8307-8318. PubMed ID: 29961319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
